ramoplanin A2

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2016
01220022016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Ramoplanin A2 is the last resort antibiotic for treatment of many high morbidity- and mortality-rated hospital infections, and it… (More)
Is this relevant?
2016
2016
Glycopeptides such as vancomycin and telavancin are essential for treating infections caused by Gram-positive bacteria. But the… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
The chemoenzymatic deacylation of ramoplanin A2 is described for the first time: ramoplanin A2 was Boc-protected and hydrogenated… (More)
  • figure 1
  • table 4
  • table 5
  • table 1
  • figure 2
Is this relevant?
2009
2009
The glycodepsipeptide antibiotic ramoplanin A2 is in late stage clinical development for the treatment of infections from Gram… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2007
2007
In efforts that define the importance of each residue and that identify key regions of the molecule, an alanine scan of the… (More)
Is this relevant?
2005
2005
3-(Diethoxyphosphoryloxy)-1, 2, 3-benzotriazin-4(3H)-one (DEPBT) is an effective coupling reagent for synthesis of linear and… (More)
  • table I
  • table II
  • table III
  • table IV
  • table V
Is this relevant?
2004
2004
Ramoplanin is a potent antibiotic, first disclosed in 1984, that acts by inhibiting bacterial cell-wall biosynthesis. The… (More)
  • figure 1
  • figure 2
Is this relevant?
2002
2002
Full details of a convergent total synthesis of the ramoplanin A2 and ramoplanose aglycon are disclosed. Three key subunits… (More)
Is this relevant?